Fortis Malar Hospitals Limited

Business overview Fortis Malar Hospitals Limited (FORTISMLR) previously operated a multi-specialty hospital. However, as of February 1, 2024, the company divested its entire business operations pertaining to Malar Hospital to MGM Healthcare Private Limited. Consequently, for the financial year ended March 31, 2026, the company no longer has any active business operations or hospital locations. Management is currently evaluating various corporate restructuring options for the future, with no visible plans for commencing new business activities.

Key facts (FY2025-26)

• Consolidated Total Income for FY2025-26 was Rs 6.35 Crores, up from Rs 2.72 Crores in FY2024-25.
• Consolidated Profit for the year FY2025-26 was Rs 4.14 Crores, compared to Rs 0.39 Crores in FY2024-25.
• The company's sole subsidiary is Fortis Healthcare Research Foundation (formerly Malar Stars Medicare Limited), a 100% owned Section 8 non-profit company.
• Fortis Hospitals Limited (the Holding Company) holds a 62.71% stake in Fortis Malar Hospitals Limited as of March 31, 2026.
• There were no permanent employees on the company's payroll as of March 31, 2026.
• The company has no hospital operations as of March 31, 2026.

Recent developments (FY2025-26)

• Strategic Evaluation: Management is evaluating various corporate restructuring options for the company's future due to the cessation of business operations.
• Subsidiary Conversion: The subsidiary, Malar Stars Medicare Limited, was converted into a Section 8 (non-profit making research) company and renamed Fortis Healthcare Research Foundation, effective August 26, 2025.
• Open Offer Completion: The mandatory open offer by Northern TK Venture Pte Limited (a subsidiary of IHH Healthcare Berhad) to acquire shares in Fortis Malar Hospitals Limited was completed on November 10, 2025.
• Board Changes: The Board of Directors saw changes, including the resignation of a Whole-time Director and the appointment/re-appointment of other Directors.
• Regulatory Fine: The company paid a fine to BSE for non-compliance in filing voting results for its Annual General Meeting held on July 30, 2025.

Key risks flagged by management (FY2025-26)

• Cessation of Business Operations: The company currently has no active business operations, and there is no clear visibility of commencing new ones in the future.
• Uncertainty of Corporate Restructuring: The ongoing evaluation of corporate restructuring options introduces significant uncertainty regarding the company's long-term strategic direction.
• Contingent Liabilities: The company faces various pending legal and tax disputes, including sales tax, income tax, GST, and patient compensation claims, which could entail future financial impacts, although management assesses the likelihood of adverse outcomes as remote for some.

Pros (FY2025-26)

• Improved Financial Performance: The company reported a substantial increase in consolidated total income and net profit for the financial year.
• Strong Liquidity: The company maintains sufficient cash and cash equivalents to settle its current and foreseeable financial obligations.
• Robust Governance: The company emphasizes strong corporate governance practices, transparency, and internal control systems.

Cons (FY2025-26)

• No Active Business Operations: The company currently has no revenue-generating business, relying heavily on "other income" for its financials.
• Uncertainty about Future: There is no clear future business plan or visibility for new operations, leading to significant strategic uncertainty.
• Absence of Employees: The company has no permanent employees on its payroll, indicating a lack of operational workforce.